Rocuronium vs vecuronium

Rocuronium is a nondepolarizing neuromuscular blocking agent with a rapid to intermediate onset depending on dose and intermediate duration. Rocuronium, like vecuronium is longer acting in infants than in children. However, unlike vecuronium, rocuronium retains the characteristics of an intermediate-acting NMBD in infants. Mechanism of action

by T Magorian 2024 Cited by 654Rocuronium 0.6 mg/kg vs: Vecuronium. Yes. No. Succinylcholine. Yes. Yes. Rocuronium 0.9 mg/kg. No. No. Rocuronium 1.2 mg/kg. Yes. Yes. Rocuronium 0.9 mg/kg vs:

5. Non-depolarizing NMBAs used for continuous infusion at UWHC include: vecuronium, rocuronium, atracurium, and cisatracurium. 5.1. Vecuronium.

0.2 mg kg 1, atracurium 0.6 mg kg, tubocurarine 0.5 mg kg, vecuronium 0.1 mg kg 1 or rocuronium 0.6 mg kg (mean (SD)). P 0.01 vs control values (within-group comparisons); P 0.05 vs vecuronium and rocuronium groups (between-group comparisons for the differences from control values); P 0.05 vs mivacurium group

Comparing Rocuronium vs Vecuronium ; Prescription only. Prescribed for Anesthesia. rocuronium may also be used for purposes not listed in this medication guide.

Present study was conducted to compare haemodynamic parameters during general anaesthesia for elective surgical procedures with vecuronium vs. rocuronium as muscle relaxant.Methods: Haemodynamic effects of vecuronium 0.15 mg/kg and 0.9 mg/kg of rocuronium was evaluated in patients (25 patients in each group) undergoing elective surgical

Rocuronium is primarily eliminated via the liver and its pharmacokinetic profile is similar to that of vecuronium bromide (vecuronium). Unlike vecuronium, rocuronium has no metabolite. Cisatracurium besilate (cisatracurium), the IR-cis, 1'R-cis isomer of atracurium besilate (atracurium) is approximately 4 times more potent than atracurium.

Rocuronium provides rapid onset of action than Vecuronium. Rocuronium is an intermediate-acting muscle relaxant as vecuronium with excellent

of rocuronium or vecuronium may shorten the time of onset of intubation and facilitate the intubation pro-cess as early as possible. This clinical trial aimed to compare the use of triple the ED 95 of rocuronium with that of vecuronium in rapid sequence induction